U.S. Machinery Stock News

We wouldn't blame Sempra ( NYSE:SRE ) shareholders if they were a little worried about the fact that Jeffrey Martin...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...

It's nice to see the DHI Group, Inc. ( NYSE:DHX ) share price up 10% in a week. But that is small recompense for the...

If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...

Those holding Insperity, Inc. ( NYSE:NSP ) shares would be relieved that the share price has rebounded 28% in the last...

If you are wondering whether Canadian Solar at around US$19.39 is a bargain or a value trap, you are not alone, especially after a volatile few years for solar stocks. The share price has fallen 18.4% over the last 7 days and 15.9% over the last 30 days, yet it is still showing a 52.2% gain over the last year after much weaker 3 and 5 year returns of 55.1% and 65.1% declines. Recent price moves sit against an ongoing global focus on renewable energy and policy support for solar projects...

Hyperscale Data (GPUS) is back in focus after releasing preliminary year end asset estimates, detailing a Bitcoin treasury that now exceeds its market capitalization and pledging more frequent balance sheet updates through 2026. See our latest analysis for Hyperscale Data. The latest balance sheet update and Bitcoin focus come after a volatile period, with a 93.68% 7 day share price return and a 30.26% year to date share price return, set against a 1 year total shareholder return of...

Arcutis Biotherapeutics (ARQT) has drawn fresh investor attention after reporting strong revenue growth tied to its dermatology pipeline, with lead product ZORYVE playing a central role even as the company continues to post operating losses. See our latest analysis for Arcutis Biotherapeutics. The recent dermatology update comes after a strong 90 day share price return of 49.03% and a 1 year total shareholder return of 95.68%. This suggests momentum has been building around Arcutis...

AMC Entertainment Holdings (AMC) is back in focus after its shares hit an all time low, even as the company reported its strongest pre Christmas weekend box office since 2021 on Avatar: Fire and Ash. See our latest analysis for AMC Entertainment Holdings. That mix of record pre Christmas box office and a new all time low share price has come after a sharp reset in expectations, with a 30 day share price return of 36.4% and a 1 year total shareholder return decline of 63.3%, suggesting...

Immuneering (IMRX) is back on traders’ screens after releasing updated Phase 2a data for atebimetinib plus modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer, showing higher overall survival and response metrics than standard benchmarks. See our latest analysis for Immuneering. The updated atebimetinib data arrive after a tough recent stretch, with the share price at US$4.73 and a 1 day share price return of 43.22% decline. However, a 1 year total shareholder return of 136.5%...

If you are wondering whether Comerica's share price still offers value after a strong run, this review will help you separate sentiment from what the numbers suggest. Comerica's stock last closed at US$92.56, with returns of 6.5% over 7 days, 10.5% over 30 days, 4.4% year to date, 55.1% over 1 year, 57.3% over 3 years and 76.8% over 5 years. Recent market attention on U.S. regional banks has kept Comerica in focus, as investors reassess how interest rate expectations and credit conditions...

Why TaskUs Stock Is Back on Investors’ Radar TaskUs (TASK) has attracted fresh attention after recent performance data highlighted mixed returns across different timeframes, prompting investors to reassess the outsourcing specialist’s valuation and business momentum. See our latest analysis for TaskUs. Recent trading has been steady rather than dramatic, with a modest 1-day share price return of 1.11% and year to date share price return of 3.85%. This is set against a weaker 1-year total...

UL Solutions recently launched a plug-in solar system testing and certification program based on UL 3700, creating a dedicated safety and performance framework for plug-in, or balcony, solar equipment connecting via standard household outlets. This move positions UL Solutions at the center of emerging U.S. policy efforts on plug-in solar, potentially giving manufacturers and regulators a common standard to enable safer, wider adoption among renters and homeowners. We’ll now explore how this...

If you are wondering whether RadNet's recent share price puts it "on sale" or already pricing in a lot of optimism, you are in the right place. RadNet closed at US$78.38, with returns of 9.9% over the last 7 days, 3.3% over 30 days, 10.5% year to date, 8.5% over 1 year, and a very large gain over 3 years that is close to 3x, plus 273.2% over 5 years. Recent coverage around RadNet has focused on the business more broadly, giving investors extra context for the current share price and those...

Lantheus Holdings has completed the sale of its SPECT business unit and reported progress in neurodegenerative imaging, including past CTAD 2025 data presentations and anticipated 2026 regulatory decisions for new beta-amyloid and tau agents, while planning a reformulated Pylarify launch to address pricing pressures. This repositioning concentrates capital and management attention on higher-growth imaging platforms, potentially altering how investors view the balance between product...

MSC Industrial Direct (MSM) opened fiscal Q1 2026 with total revenue of US$965.7 million and basic EPS of US$0.93, alongside net income excluding extra items of US$51.8 million, providing an updated view of how its margins are holding up. Over recent quarters, the company has reported revenue of US$952.3 million in Q4 2024, US$928.5 million in Q1 2025, and US$965.7 million in Q1 2026. EPS over the same periods was US$0.99, then US$0.83, and now US$0.93, which puts the latest results in...

Some investors are considering whether Toro's current share price aligns with its underlying worth, or if recent market interest has pushed it away from that level. Toro's stock has recently traded at US$87.87, with returns of 11.6% over the last 7 days, 26.1% over 30 days, 9.6% year to date, 13.2% over 1 year, but declines of 20.0% over 3 years and 5.3% over 5 years. Recent attention on Toro has focused on how its long-term share performance compares with shorter-term gains, which has put...

Viridian Therapeutics (VRDN) is in focus after the FDA accepted its Biologics License Application for veligrotug in thyroid eye disease under Priority Review, while multiple late stage programs and pipeline updates continue to attract investor attention. See our latest analysis for Viridian Therapeutics. Despite a softer patch recently, with a 30 day share price return of 4.62% and a 7 day share price return of 2.54%, Viridian’s 90 day share price return of 44.50% and 1 year total shareholder...

If you are wondering whether Cincinnati Financial's current share price reflects its true worth, you are not alone. That is exactly what this article is set up to unpack. The stock last closed at US$165.19, with returns of 1.1% over 7 days, 2.3% over 30 days, 2.3% year to date, 19.3% over 1 year, 65.3% over 3 years and 99.9% over 5 years, which gives useful context before looking at what the valuation suggests. Recent coverage around the insurance sector more broadly has kept investor...

If you are wondering whether Church & Dwight’s current share price reflects its true worth, you are not alone. This article walks through what the numbers are saying about value. The stock recently closed at US$85.86, with returns of 2.4% over the last 7 days, 3.9% over the last 30 days and year to date, and a 15.2% decline over the past year, which raises questions about how the market is currently pricing its prospects and risks. Recent company updates and broader sector news have kept...

Constellation Brands (STZ) has just posted Q3 2026 results with revenue of US$2,222.8 million and basic EPS of US$2.88, while trailing twelve month revenue came in at US$9.4 billion and EPS at US$6.27. Over recent quarters, revenue has ranged from US$2,164.2 million in Q4 2025 to US$2,515 million in Q1 2026, with basic EPS moving from a loss of US$2.09 in Q4 2025 to positive readings between US$2.65 and US$2.90 across 2026 so far. This sets up the latest quarter against a backdrop of shifting...

CureVac N.V. recently closed its August 14, 2020 shelf registration in the amount of €3.21 million, covering 26,768,980 common shares for an ESOP-related offering. A day earlier, CureVac was removed from the NASDAQ Composite Index, a change that can influence trading behavior as index-tracking investors rebalance their holdings. We will now examine how CureVac’s removal from the NASDAQ Composite Index may influence its pre-existing investment narrative and risk profile. Uncover the next big...

If you are wondering whether Magnolia Oil & Gas is attractively priced today, the key question is how its current share price lines up with its underlying business value. The stock closed at US$22.21 most recently, with returns of 1.5% over the last 7 days, a 2.8% decline over 30 days, a 1.2% decline year to date, a 6.1% decline over 1 year, a 0.2% gain over 3 years, and a 172.0% gain over 5 years. Recent coverage of Magnolia Oil & Gas has focused on its share price performance over...

Kenvue has appointed Madhav Nayak as Vice President and Chief Marketing Officer for the Asia-Pacific region, drawing on his prior leadership roles at Yum! Brands, Meta, and Unilever across marketing, strategy, digital, and commercial functions. By bringing in a CMO with deep experience building global consumer brands in Asia, Kenvue is signaling a stronger push to sharpen its marketing and digital execution in one of its most important growth regions. Next, we’ll explore how Nayak’s...